ISMB 2026, Washington, D.C.
Nygen presents in the ISMB 2026 Tech Track. Parashar Dhapola, CEO, on leveraging LLMs for accurate and confidence-calibrated cell type and state identification.
Read more →Resources
A curated index of articles, updates, events, and published work across single-cell research.
Johnson & Johnson R&D Symposium 2026, Beerse
Meet Nygen at the Johnson & Johnson R&D Symposium 2026 in Beerse, Belgium, June 18. Parashar Dhapola, CEO, will be on site for conversations on single-cell analytics and virtual biology for drug discovery.
Read more →
Drug Discovery Europe 2026, Berlin
Meet Nygen at Drug Discovery Europe 2026 in Berlin, June 15 to 16. Find us in the Data and AI Zone for conversations on single-cell analytics and AI for drug discovery.
Read more →
Festival of Genomics, Biodata & AI 2026, Boston
Nygen is an Agenda Partner at Festival of Genomics Boston 2026. Parashar Dhapola, CEO, presents on druggable cell populations missed by standard annotation on the Single-Cell Stage.
Read more →
Keystone Symposia: Computational Advances in Drug Discovery 2026
Nygen at Keystone Symposia Computational Advances in Drug Discovery in London, May 7 to 10, 2026. Short talk by Parashar Dhapola, CEO, on multi-agent AI for evidence-based cell type annotation.
Read more →
Global Innovation Summit 2026, Basel
Meet Nygen at the Global Innovation Summit 2026 in Basel on May 6. Constance Beyer, Fractional CBO, will be on site for partnering conversations on single-cell analytics and AI for drug discovery.
Read more →
Swiss Biotech Day 2026, Basel
Meet Nygen at Swiss Biotech Day 2026 in Basel on May 4 and 5. Constance Beyer, Fractional CBO, will be on site for partnering conversations on single-cell analytics and AI for drug discovery.
Read more →
25th BioPharma Drug Discovery Nexus 2026, Zurich
Nygen at the 25th BioPharma Drug Discovery Nexus in Zurich, April 29–30, 2026. Session with Parashar Dhapola on AI agents versus AI workflows for single-cell annotation at scale.
Read more →
QIAGEN Agentic AI and Data Innovation Summit 2026, Basel
Meet Nygen at the QIAGEN Agentic AI and Data Innovation Summit in Basel on April 22, 2026. Constance Beyer, Fractional CBO, will be on site for conversations on AI, knowledge graphs, and single-cell data for drug discovery.
Read more →
VLP Therapeutics Teams with Swedish AI Biotech Nygen Analytics on Vinnova-Funded Cancer Immunotherapy Research
Nygen Analytics wins 1M SEK Vinnova grant to develop AI-powered predictive models for cancer immunotherapy with VLP Therapeutics, advancing personalized treatment selection.
Read more →
Why We Built AI Agents That Actually Understand Single Cell Data
CyteType is multi-agentic annotation system designed for single-cell RNA-seq cluster annotation. Designed to deploy three specialized AI agents to provide accurate cell type identification, literature validation, and pathway-level reasoning beyond traditional marker-based methods and beyond. Built for researchers seeking precise, evidence-backed single-cell data analysis with comprehensive biological context.
Read more →
Nygen Secures ISO 27001 and SOC 2 Certifications
Nygen Analytics, the only single-cell–focused omics data-analytics platform to pair ISO 27001 certification and SOC 2 compliance with full GDPR alignment
Read more →
AGI is Far, but ASI is Here
Explore how ASI transforms drug discovery by harnessing domain-specific models and advanced computing tools for faster, smarter biomedical innovation.
Read more →